CooperVision Names Rajeev Garg, PhD, as Global Head of Myopia Management Strategy

More Images
SAN RAMON, Calif.—CooperVision on Monday announced the appointment of Rajeev Garg, PhD, as global head of myopia management strategy. In this newly created role, he leads various myopia-related initiatives, including market development, acquisitions and joint ventures, technology licensing, and lifecycle management in this growing segment of vision care. Garg brings more than 20 years of experience in driving innovation and growth in health care, including optometry and ophthalmology. He most recently served as executive director, surgical marketing at Bausch + Lomb, and previously held senior marketing roles within Johnson & Johnson’s cataract, contact lens and sterilization businesses. Earlier in his career, he focused on pharmaceutical development at Abbott and Merck.

In November, CooperVision announced that the FDA had approved its innovative MiSight 1 day contact lens, the cornerstone of the company’s myopia management initiative, as VMAIL reported.

“Continuing to advance myopia management requires expanded investment in science and technology, as well as adding to an already strong team of visionary, experienced and passionate people,” CooperVision president of specialty eyecare Dr. Juan Carlos Aragon said in the announcement. “Garg’s proven expertise will be invaluable as we pioneer new techniques, introduce new products, and establish new collaborations to address the global myopia epidemic.”

Garg received his PhD in chemical engineering (medical devices) from Princeton University, an MBA in strategy, health care and marketing from Northwestern University’s Kellogg School of Management, and a B.Tech in chemical engineering from the Indian Institute of Technology. He resides in California with his wife and family.

CooperVision, a division of the CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses.